Recent studies confirming the possible detrimental effects of hormone replacement therapy (HRT) caused many women to discontinue the treatment. However, many postmenopausal women who discontinue HRT experience a rapid decline in bone density, as reported by Johns Hopkins.
More About Fosamax
Osteoporosis Risk Factors
Bone Up on Osteoporosis
What Should People With Arthritis Be Doing to Prevent Osteoporosis?
Does Osteoporosis Risk Increase for People With Rheumatic Disease?
What You Need to Know About Corticosteroid-Induced Osteoporosis
Fosamax (alendronate) is effective for increasing or maintaining bone mass density, as well as decreasing the rate of bone loss, in postmenopausal women.
Related Resources:
Comments
No comments yet. Leave a Comment
